Article Versions Notes

Singh A, Singh K, Kaur K, Singh A, Sharma A, Kaur K, Kaur J, Kaur G, Kaur U, Kaur H, et al. Coumarin as an Elite Scaffold in Anti-Breast Cancer Drug Development: Design Strategies, Mechanistic Insights, and Structure–Activity Relationships. Biomedicines. 2024; 12(6):1192. https://doi.org/10.3390/biomedicines12061192

Singh, Atamjit, Karanvir Singh, Kamaljit Kaur, Amandeep Singh, Aman Sharma, Kirandeep Kaur, Jaskirat Kaur, Gurleen Kaur, Uttam Kaur, Harsimran Kaur, and et al. 2024. "Coumarin as an Elite Scaffold in Anti-Breast Cancer Drug Development: Design Strategies, Mechanistic Insights, and Structure–Activity Relationships" Biomedicines 12, no. 6: 1192. https://doi.org/10.3390/biomedicines12061192

Singh, A., Singh, K., Kaur, K., Singh, A., Sharma, A., Kaur, K., Kaur, J., Kaur, G., Kaur, U., Kaur, H., Singh, P., & Bedi, P. M. S. (2024). Coumarin as an Elite Scaffold in Anti-Breast Cancer Drug Development: Design Strategies, Mechanistic Insights, and Structure–Activity Relationships. Biomedicines, 12(6), 1192. https://doi.org/10.3390/biomedicines12061192